Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
作者信息
WARNOCK C G, NEILL D W
出版信息
J Neurol Neurosurg Psychiatry. 1954 Feb;17(1):70-4. doi: 10.1136/jnnp.17.1.70.
Abstract
摘要
相似文献
1
Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
J Neurol Neurosurg Psychiatry. 1954 Feb;17(1):70-4. doi: 10.1136/jnnp.17.1.70.
2
The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
N Engl J Med. 1951 Dec 13;245(24):917-25. doi: 10.1056/NEJM195112132452401.
3
The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
Trans Am Neurol Assoc. 1951;56:79-84.
4
Penicillamine, a new oral therapy for Wilson's disease.
Am J Med. 1956 Oct;21(4):487-95. doi: 10.1016/0002-9343(56)90066-3.
5
DIMERCAPROL for hepatolenticular degeneration.
Lancet. 1952 Jan 26;1(6700):199-200.
6
[BAL (2, 3-dimercaptopropanol) therapy of hepatolenticular degeneration].
Suvr Med (Sofiia). 1955;6(7):96-100.
7
Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy.
AMA Arch Intern Med. 1953 Apr;91(4):541-9. doi: 10.1001/archinte.1953.00240160127009.
8
[On BAL treatment of hepatolenticular degeneration].
Med Klin. 1956 Jan 20;51(3):107-8.
9
[Biochemistry of hepatolenticular degeneration; its treatment with BAL].
Bull Med. 1953 Jun 15;67(12):333-5.
10
[Case of hepatolenticular degeneration treated by BAL].
Neurol Neurochir Psychiatr Pol. 1956 Sep-Oct;6(5):541-7.
引用本文的文献
1
Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D-Penicillamine Therapy: A Single Centre Experience.
Ann Indian Acad Neurol. 2022 Jul-Aug;25(4):698-702. doi: 10.4103/aian.aian_519_21. Epub 2022 Sep 9.
2
[Studies on the pathogenesis of kuru; a clinical, pathological and epidemiological study of a chronic, progressive, degenerative disease of the central nervous system achieving epidemic proportions among the natives of the Eastern Highlands of New Guinea].
Klin Wochenschr. 1958 May 15;36(10):445-59. doi: 10.1007/BF01484635.
本文引用的文献
1
Micro-determination of copper in biological material.
Biochem J. 1940 Sep;34(8-9):1202-8. doi: 10.1042/bj0341202.
2
Amino-aciduria and copper metabolism in hepatolenticular degeneration.
J Clin Pathol. 1952 Feb;5(1):16-24. doi: 10.1136/jcp.5.1.16.
3
The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
N Engl J Med. 1951 Dec 13;245(24):917-25. doi: 10.1056/NEJM195112132452401.
4
Hepatolenticular degeneration; biochemical observations in children with and without neurological symptoms; hyperamino-aciduria.
Acta Med Scand. 1951;140(5):374-80.
5
Copper excretion in the urine of normal individuals and of patients with hepatolenticular degeneration (Wilson's disease).
Arch Biochem Biophys. 1951 Apr;31(2):262-5. doi: 10.1016/0003-9861(51)90213-5.
6
The metabolic disorder in hepato-lenticular degeneration.
Q J Med. 1952 Oct;21(84):425-46.
7
Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
Science. 1952 Oct 31;116(3018):484-5. doi: 10.1126/science.116.3018.484.
Zotero 插件